@Gandeeva_Tx raises $40M Series A funding by leveraging #ai-based understandings of structural biology and interactions combined with precision imaging for drug development #CryoEM https://t.co/9JOuxlpWlp via @techcrunch
Excited to announce our US$40 million Series A funding led by @Lux_Capital and @LeapsByBayer! Our AI-driven #cryoEM platform aims to accelerate the discovery, design and development of novel precision medicines and breakthrough cures to patients https://t.co/XLagglLBg3 @UBC
Thrilled to announce the launch of @Gandeeva_Tx! Our mission is to harness the power of computation and experimentation to enable breakthroughs in precision medicine.
Sriram Subramaniam and Gerard Kleywegt discuss how structure prediction and cryo-EM/cryo-ET will synergize to tackle challenging biological questions regarding conformational dynamics and in situ structure analysis.
@cryoem_UBC@UBC@emblebi @PDBeudrope
https://t.co/LEw2xxwdwQ
Thank you @wired@tsimonite for featuring our work on the Omicron variant. AI predictions continue to become increasingly central and transformative for structural biology, however the gold standard will always be direct measurement, and that’s what #cryoEM delivers.
Delighted to have contributed a commentary article for Nature Method’s Method of the Year 2021 issue! Machine learning based predictions and #cryoEM technology are the new yin and yang of structural biology. The mix is a game-changer for drug discovery: https://t.co/IbHzkC6FB5
#CryoEM structure of #Omicron (B.1.1.529) variant spike protein in complex with human ACE2 reveals new salt bridges formed by mutated residues R498 and R493 in the RBD and residues D38 and E35, respectively, in ACE2.
BREAKING: 'A milestone in oncology’: $AMGN KRAS-blocking drug proves effective for lung cancer... https://t.co/D7jkjuiuWK Sotorasib data released early due to #WCLC20 embargo break.
mTOR suppresses PD-L1 expression in tumor cells, pointing to antagonistic roles for mTOR signaling in oncogenesis. #immunotherapy https://t.co/nsyWnjLciu